Doxycycline Delayed-Release Tablets Suppliers & Bulk Manufacturers

Available Forms: Doxycycline Delayed-Release Tablets

Available Strengths: 50 mg, 60 mg, 75 mg, 80 mg, 100 mg, 150 mg, 200 mg.5 Feb 2025

Reference Brands: Vibramycin (US & EU)

Category: Antibiotics

Doxycycline Delayed-Release Tablets is available in Doxycycline Delayed-Release Tablets and strengths such as 50 mg, 60 mg, 75 mg, 80 mg, 100 mg, 150 mg, 200 mg.5 Feb 2025. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Doxycycline Delayed-Release Tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Doxycycline Delayed-Release Tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Doxycycline delayed-release tablets and capsules are approved in the EU and US for treating respiratory, urinary, and skin infections. In the EU, brands like Vibramycin XR are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval is based on extensive clinical data, with generics widely available. Both regions require detailed dossiers, including clinical trial results, quality assurance, and pharmacovigilance plans for approval and ongoing safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate seamless market access for doxycycline XR formulations, ensuring adherence to European and US standards for safe, effective antibiotic therapy.